In this edition of The People’s Pharmacy, Joe and Teresa Graedon also hear from a reader whose husband found a solution for seborrheic dermatitis on his scalp.
Orforglipron is a new oral GLP-1 drug that outperforms oral semaglutide in blood sugar control and weight loss while offering ...
Boehringer Ingelheim’s glucagon/GLP-1 dual agonist has driven 16.6% weight loss at Week 76 of a phase 3 study. While the ...
2don MSN
Boehringer Ingelheim’s obesity drug helps lose fat rather than muscle, late-stage trial shows
EXCLUSIVE: Survodutide shows potential to predominantly target visceral fat, its Chief Executive Shashank Deshpande said in ...
Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the ...
Incretin-based obesity medications may result in higher muscle-related loss vs. other weight loss strategies, according to data published in Annals of Internal Medicine.The findings “suggest that ...
Here’s what a new study says.
2d
Former model on how she dropped 105 pounds without Ozempic — and the ‘reality’ of major weight loss
Deborah Gregory, a former international runaway model who went on to create the mega-popular book series “The Cheetah Girls,” ...
The tool was developed using extensive data from 200,000 middle-aged adults participating in the UK Biobank study ...
Experts say GLP-1 drugs offer benefits beyond weight loss, but common mistakes like skipped labs and poor nutrition can ...
Eli Lilly has more to offer than some investors realize.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results